Millennium Management
APTO

Millennium Management’s Aptose Biosciences, Inc. APTO Stock Holding History

Millennium Management’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-127
Closed -$37K – 7038
2023
Q1 		$37K Sell
127
-368
-74% -$107K ﹤0.01% 5721
2022
Q4 		$129K Buy
495
+212
+75% +$56.9K ﹤0.01% 5499
2022
Q3 		$76K Sell
283
-41
-13% -$14.1K ﹤0.01% 6059
2022
Q2 		$108K Sell
324
-1,399
-81% -$669K ﹤0.01% 5896
2022
Q1 		$1.05M Sell
1,723
-702
-29% -$388K ﹤0.01% 4468
2021
Q4 		$1.47M Buy
2,425
+886
+58% +$833K ﹤0.01% 4050
2021
Q3 		$1.51M Buy
1,539
+838
+120% +$1.05M ﹤0.01% 4230
2021
Q2 		$1.05M Sell
701
-111
-14% -$242K ﹤0.01% 4618
2021
Q1 		$2.18M Buy
812
+370
+84% +$734K ﹤0.01% 3450
2020
Q4 		$871K Buy
442
+55
+14% +$129K ﹤0.01% 3824
2020
Q3 		$1.04K Buy
387
+21
+6% +$52.4K ﹤0.01% 3100
2020
Q2 		$1.04M Sell
366
-1,417
-79% -$4.57M ﹤0.01% 2969
2020
Q1 		$4.77M Sell
1,783
-62
-3% -$185K 0.01% 1366
2019
Q4 		$4.71M Buy
+1,845
New +$2.4M 0.01% 1984

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
AC
Annandale Capital Dallas, Texas $709M AUM 11.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Millennium Management's APTO Position: Q2 2023 in Review

Millennium Management sold out of Aptose Biosciences, Inc. (APTO) in Q2 2023, closing a stake of 127 shares — an estimated $37K sold.

Millennium Management first reported a position in APTO in Q4 2019 and held it in 14 quarters. The position peaked at $4.77M in Q1 2020. 24 funds tracked by Wall St. Rank hold APTO as of Q2 2023.

  • Millennium Management reported no remaining Aptose Biosciences, Inc. position as of Q2 2023 after selling out during the quarter.
  • Millennium Management sold 127 Aptose Biosciences, Inc. shares in Q2 2023, an estimated $37K.
  • Millennium Management first reported a position in Aptose Biosciences, Inc. in Q4 2019 and held it in 14 quarters.
  • Millennium Management's Aptose Biosciences, Inc. position peaked at $4.77M in Q1 2020.
  • 24 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q2 2023.

Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.